SIGLEC9 and esophageal squamous cell carcinoma: The radioresistance of ESCCs stimulated by the TAMs was reduced upon SIGLEC9 blockade, as manifested by significantly suppressed DNA synthesis capacity, migration, and invasion of the ESCC cells (Fig. 3d–f), along with increased cell necrosis (Fig. 3g).